Fauci, Navarro reportedly got into a heated dispute over unproven coronavirus treatment

A fight broke out in the White House Situation Room on Saturday, after President Trump's economic adviser Peter Navarro clashed with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, over an unproven COVID-19 coronavirus treatment, Axios reports.
Four people with knowledge of the matter told Axios' Jonathan Swan the argument took place near the end of a White House coronavirus task force meeting, after Food and Drug Administration Commissioner Stephen Hahn brought up hydroxychloroquine, an antimalarial drug Trump has touted as a possible "game-changer" in the fight against coronavirus. When Hahn was finished giving updates on drug trials, Navarro put folders down on the table where Hahn, Fauci, Vice President Mike Pence, and others were sitting.
One person familiar with the conversation told Swan the "first words out of his mouth are that the studies that he's seen, I believe they're mostly overseas, show 'clear therapeutic efficacy.' Those are the exact words out of his mouth." Fauci responded that this was anecdotal evidence, and this "just set Peter off," Swan reports. Navarro pointed to the folders and said, "That's science, not anecdote," a source said, and as his voice continued to get louder, Pence tried to intervene. "It was pretty clear that everyone was just trying to get Peter to sit down and stop being so confrontational," another person told Swan.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Fauci and other public health officials have said more data is needed before anyone can say the drug is effective against COVID-19, but based on things he's read, Navarro is convinced it works, Swan reports. The task force ultimately decided that publicly, the White House needs to say that use of hydroxychloroquine is between doctors and patients. Read more at Axios.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Amazon's 'James Bond' deal could mean a new future for 007
In the Spotlight The franchise was previously owned by the Broccoli family
By Justin Klawans, The Week US Published
-
Why are Republicans suddenly panicking about DOGE?
TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
By Rafi Schwartz, The Week US Published
-
What is JD Vance's Net Worth?
In Depth The vice president is rich, but not nearly as wealthy as his boss and many of his boss' appointees
By David Faris Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published